A clinical and translational phase II trial of sequential axitinib and carboplatin/paclitaxel in advanced melanoma.

被引：0
|
作者：
Algazi, Alain Patrick [1 ]
Cha, Edward [1 ]
Pampaloni, Miguel H. [1 ]
Behr, Spencer [1 ]
Cortez, Brandon [1 ]
Quiroz, Anteo [1 ]
Coakley, Fergus V. [1 ]
Liu, Songling [1 ]
Daud, Adil [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8580
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II clinical/translational trial of sequential axitinib/carboplatin/paclitaxel in melanoma
    Algazi, A. P.
    Cha, E.
    Soon, C.
    Ortiz-Urda, S.
    Cortez, B.
    Ziani, L.
    Coakley, F. V.
    Daud, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Phase II trial of carboplatin, paclitaxel and temozolomide in metastatic melanoma.
    Araujo-Mino, Emilio Paul
    Shaheen, Montaser F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial
    A P Algazi
    E Cha
    S M Ortiz-Urda
    T McCalmont
    B C Bastian
    J Hwang
    M H Pampaloni
    S Behr
    K Chong
    B Cortez
    A Quiroz
    F Coakley
    S Liu
    A I Daud
    [J]. British Journal of Cancer, 2015, 112 : 1326 - 1331
  • [4] The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial
    Algazi, A. P.
    Cha, E.
    Ortiz-Urda, S. M.
    McCalmont, T.
    Bastian, B. C.
    Hwang, J.
    Pampaloni, M. H.
    Behr, S.
    Chong, K.
    Cortez, B.
    Quiroz, A.
    Coakley, F.
    Liu, S.
    Daud, A. I.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (08) : 1326 - 1331
  • [5] PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED MELANOMA
    CASPER, ES
    BAJORIN, D
    [J]. INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 187 - 190
  • [6] Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group
    Urosevic, V
    Chollet, P
    Adenis, A
    Chauvergne, J
    Fargeot, P
    Roche, H
    Kerbrat, P
    Lentz, MA
    Fumoleau, P
    Chevallier, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 181 - 182
  • [7] Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma
    Redman, BG
    Smith, DC
    Flaherty, L
    Du, W
    Hussain, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1844 - 1848
  • [8] Phase II trial of weekly paclitaxel in patients with advanced melanoma
    Walker, L
    Schalch, H
    King, DM
    Dietrich, L
    Eastman, M
    Kwak, M
    Kim, K
    Albertini, MR
    [J]. MELANOMA RESEARCH, 2005, 15 (05) : 453 - 459
  • [9] Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.
    Taylor, Matthew H.
    Vogelzang, Nicholas J.
    Cohn, Allen Lee
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Guo, Matthew
    Schmidt, Emmett V.
    Rasco, Drew W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [10] PHASE-II TRIAL OF CARBOPLATIN IN ADVANCED MALIGNANT-MELANOMA
    EVANS, LM
    CASPER, ES
    ROSENBLUTH, R
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (02): : 171 - 172
12345